CORT
Corcept Therapeutics Incorporated
$112.73
▼ -1.54%
−$1.76
NYSE · Healthcare · Biotechnology
· price updated 9h ago
Corcept Therapeutics Incorporated
CORT · NYSE · Healthcare · Biotechnology · price updated 9h ago
$112.73
▼ -1.54% · −$1.76 today
AI research · $112.73
CORT, researched
Q2 beat and raised guidance re-rate the story
refreshed Jul 31
price position
Where CORT sits now
52-week range
Low$28.66
High$95.79
Today $112.73
RSI (14)
67.3Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$308.2M
Total debt$9.4M
Net cash after debt$298.8M
Valuation
What the market charges
Forward P/E
Price against expected earnings
Needs attention · 87% above Sector avg
28.97x
Price / sales
Value assigned to each sales dollar
Rich · Above 8x annual sales
14.90x
Price / FCF
Price against free cash generation
Rich · Above 35x free cash flow
115.75x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
1402.29x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
1.8%
ROE
Profit generated from shareholder equity
Needs attention · Lagging most sector peers
8.2%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.01x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
2.86x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How CORT compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $12.38B | 273.4 | +16.0% | 52 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Corcept Therapeutics Incorporated (CORT) stock
Corcept Therapeutics Incorporated tracked in the US core universe. CORT was -1.5% in the latest available session at $112.73. Its reported market value was $12.38B with a trailing P/E of 273.4. Latest reported revenue was $830.81M, changing +16.0% year over year, with $54.20M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $112.73
- Day change
- -1.5%
- Market cap
- $12.38B
- P/E (TTM)
- 273.4
- Revenue growth
- +16.0%
- Industry
- Biotechnology